Company
Pfizer
Official Name: Pfizer Inc.
Headquarters: New York, NY, United States
Founded: 1849
Employees: 79,000
CEO: Dr. Albert Bourla D.V.M., DVM, Ph.D.
Market Cap
$156.96 Billion
USD as of July 1, 2024
Company Description
Pfizer Inc. is one of the world's largest pharmaceutical corporations, developing and producing diverse medicines and vaccines. Its leading products include Lipitor (to lower LDL blood cholesterol), Lyrica (for neuropathic pain and fibromyalgia), Diflucan (antifungal medication), Zithromax (antibiotic), Viagra (for erectile dysfunction), and Celebrex (anti-inflammatory drug).
Top Competitors by Market Capitalization
Industry: Drug Manufacturers—General
| Company | Market Cap (USD) |
|---|---|
| Lilly | $808.65 B |
| Johnson & Johnson | $350.63 B |
| Merck | $318.75 B |
| AbbVie | $295.34 B |
| AstraZeneca | $236.45 B |
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $808.65 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $450.89 B |
| Johnson & Johnson | $350.63 B |
| Merck | $318.75 B |
Detailed Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Top 1-year algo backtest: +265.99%
$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Stocks & Indices
Pfizer Inc. has the following listings and related stock indices.
Stock: NYSE: PFE wb_incandescent
Stock: BCBA: PFE wb_incandescent
Stock: BMV: PFE wb_incandescent
Stock: Bovespa: PFIZ34 wb_incandescent
Stock: BVS: PFE wb_incandescent
Stock: MTA: PF.U wb_incandescent
Stock: XETR: PFE wb_incandescent
Product & Services
Pharmaceuticalsgeneric drugsover-the-counter drugsvaccinesdiagnosticscontact lensesanimal health(list...)
Key People
Founder(s): Charles Pfizer Charles F. Erhart
Albert Bourla, CEO Frank A. D’ Amelio, CFO Scott Gottlieb, Director Helen Hobbs, Director Susan Hockfield, Director Dan Littman, Director Shantanu Narayen, Director Suzanne Nora Johnson, Director James Quincey, Director Jim Smith, Director
Financials
Revenue: $41.908 billion (2020)
Operating income: $7.497 billion (2020)
Net income: $9.616 billion (2020)
Total assets: $154.229 billion (2020)
Total equity: $63.473 billion (2020)